NCT03314298View on ClinicalTrials.gov

A Single Dose Trial to Evaluate the Pharmacokinetics of Testosterone and Anastrozole

PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

August 14, 2017

Primary Completion Date

April 17, 2018

Study Completion Date

April 17, 2018

Conditions
Mammographic Density
Interventions
DRUG

testosterone anastrozole

subcutaneous testosterone and anastrozole

Trial Locations (1)

5065

Wellend Health, Toorak Gardens

Sponsors
All Listed Sponsors
lead

Havah Therapeutics Pty Ltd

INDUSTRY

NCT03314298 - A Single Dose Trial to Evaluate the Pharmacokinetics of Testosterone and Anastrozole | Biotech Hunter | Biotech Hunter